While many ETFs simply mirror an index, VEGA utilizes a sophisticated, multi-layered strategy that aims to manage risk and provide a more consistent experience for the long-term investor.
At the heart of VEGA is a buy-write (covered call) strategy. This approach seeks efficiency and income generation.
Think of it as generating an "income overlay" on top of traditional holdings. The fund holds a diversified portfolio of assets and sells call options against them. This process converts a portion of the market's potential movement into immediate cash flow.
VEGA distinguishes itself by moving beyond a single asset class. It employs a comprehensive framework to insulate the portfolio:
How Has VEGA Performed During Corrections?
Who is VEGA For?
VEGA is not intended to track the full upward trajectory of a singular, aggressive bull market; the same strategy that mitigates downside risk also caps maximum upside. Instead, it is a tool for disciplined, conservative growth.
By targeting a 0.65 beta, the fund aims to deliver roughly two-thirds of the broad market's movement. For investors transitioning toward a wealth-preservation phase or those seeking a "core" allocation that prioritizes stability, VEGA offers institutional-grade portfolio management within a transparent and liquid ETF structure.
|
— For Institutional Investor Use Only. Not for Public Distribution —
|
| Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information is in the prospectus and summary prospectus, a copy of which may be obtained by visiting the Fund’s website at www.AdvisorShares.com. Please read the prospectus carefully before you invest. Foreside Fund Services, LLC, distributor. An investment in the Funds is subject to risk, including the possible loss of principal amount invested. The risks associated with each Fund include the risks associated with the underlying ETFs, which can result in higher volatility, and are detailed in each Fund’s prospectus and on each Fund’s webpage. AIL-887489-2026-02-17 |